Ishibashi A, Hanagata R, Horii D, Hisayama T, Takayanagi I
Nihon Yakurigaku Zasshi. 1983 Nov;82(5):361-73.
The mode for the antispasmodic action of suloctidil was examined using aorta strips of rats in vitro. Both 10 microM suloctidil and 0.1 microM verapamil non-competitively inhibited the norepinephrine (NE)-induced contraction, of which pD'2 values were 4.61 +/- 0.41 and 6.16 +/- 0.22, respectively. Prazosin at 1 nM competitively inhibited the NE-induced contraction, and its pA2 value was 9.84 +/- 0.15. In the depolarized aorta, suloctidil competitively inhibited the CaCl2-induced contraction at the concentrations of 0.1 and 1.0 microM, of which the pA2 value was 5.96 +/- 0.26. However, 10 microM suloctidil inhibited the CaCl2-induced contraction in a non-competitive manner, and its pD'2 value was 5.01 +/- 0.14. The pA2 values for papaverine, verapamil and cinnarizine were found to be 5.23 +/- 0.10, 7.53 +/- 0.09 and 7.11 +/- 0.11 in CaCl2 induced contraction, respectively. In a Ca2+ free medium, 1 microM NE caused a transient contraction, which was maximum (23.8 +/- 2.2% of that in a normal solution) at 0.4 min after the application of NE. Subsequent application of 2.5 and 10 mM CaCl2 evoked a gradual contractile response, of which the maximum was 103.1 +/- 4.2% and 133.8 +/- 10.3% of that in a normal solution, respectively. Initial phasic contraction induced by NE in a Ca2+ free medium was not affected by 10 microM suloctidil nor by 0.1 microM verapamil, while this contraction was significantly suppressed by 1 nM prazosin. The tonic contraction, however, induced by re-application of CaCl2 was significantly suppressed by 10 microM suloctidil, 0.1 microM verapamil and 1 nM prazosin. Furthermore, 1.0 microM suloctidil and 0.1 microM verapamil significantly suppressed the 45Ca uptake into the depolarized aorta 5 and 10 min after the addition of 45CaCl2. On the contrary, suloctidil had no influence on the phosphodiesterase activity prepared from the aorta of rats even at 10 microM, whereas 1.0 microM papaverine inhibited the enzyme activity. It is concluded that suloctidil and verapamil inhibit the contractions of the isolated rat aorta induced by NE and CaCl2 through the inhibition of the influx of Ca2+ without affecting the intracellular Ca2+ release.
采用大鼠离体主动脉条研究了舒洛地尔的抗痉挛作用方式。10微摩尔/升的舒洛地尔和0.1微摩尔/升的维拉帕米均非竞争性抑制去甲肾上腺素(NE)诱导的收缩,其pD'2值分别为4.61±0.41和6.16±0.22。1纳摩尔的哌唑嗪竞争性抑制NE诱导的收缩,其pA2值为9.84±0.15。在去极化的主动脉中,舒洛地尔在0.1和1.0微摩尔/升浓度下竞争性抑制氯化钙诱导的收缩,其pA2值为5.96±0.26。然而,10微摩尔/升的舒洛地尔以非竞争性方式抑制氯化钙诱导的收缩,其pD'2值为5.01±0.14。在氯化钙诱导的收缩中,罂粟碱、维拉帕米和桂利嗪的pA2值分别为5.23±0.10、7.53±0.09和7.11±0.11。在无钙培养基中,1微摩尔/升的NE引起短暂收缩,在应用NE后0.4分钟时达到最大值(为正常溶液中收缩的23.8±2.2%)。随后应用2.5和10毫摩尔/升的氯化钙引起逐渐增强的收缩反应,其最大值分别为正常溶液中收缩的103.1±4.2%和133.8±10.3%。在无钙培养基中由NE诱导的初始相收缩不受10微摩尔/升的舒洛地尔和0.1微摩尔/升的维拉帕米影响,而该收缩被1纳摩尔的哌唑嗪显著抑制。然而,重新应用氯化钙诱导的强直收缩被10微摩尔/升的舒洛地尔、0.1微摩尔/升的维拉帕米和1纳摩尔的哌唑嗪显著抑制。此外,1.0微摩尔/升的舒洛地尔和0.1微摩尔/升的维拉帕米在加入45氯化钙后5分钟和10分钟时显著抑制45钙摄取进入去极化的主动脉。相反,舒洛地尔即使在10微摩尔/升时对从大鼠主动脉制备的磷酸二酯酶活性也无影响,而1.0微摩尔/升的罂粟碱抑制该酶活性。结论是舒洛地尔和维拉帕米通过抑制钙离子内流而不影响细胞内钙离子释放来抑制NE和氯化钙诱导的离体大鼠主动脉收缩。